These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8713470)

  • 21. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.
    Niedobitek G; Agathanggelou A; Nicholls JM
    Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency.
    Kurth J; Spieker T; Wustrow J; Strickler GJ; Hansmann LM; Rajewsky K; Küppers R
    Immunity; 2000 Oct; 13(4):485-95. PubMed ID: 11070167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
    Hui KF; Tam KP; Chiang AKS
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29160853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The promise of a prophylactic Epstein-Barr virus vaccine.
    Balfour HH; Schmeling DO; Grimm-Geris JM
    Pediatr Res; 2020 Jan; 87(2):345-352. PubMed ID: 31641280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma.
    Murray PG; Young LS
    Blood; 2019 Aug; 134(7):591-596. PubMed ID: 31186275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epstein-Barr virus (EBV)].
    Seigneurin JM
    Rev Prat; 1999 Dec; 49(20):2217-21. PubMed ID: 10731805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus associated diseases: an update.
    Pathmanathan R
    Malays J Pathol; 1993 Dec; 15(2):105-13. PubMed ID: 8065170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays.
    Bell AI; Groves K; Kelly GL; Croom-Carter D; Hui E; Chan ATC; Rickinson AB
    J Gen Virol; 2006 Oct; 87(Pt 10):2885-2890. PubMed ID: 16963746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epstein-Barr virus infections. New pathogenic and clinical aspects].
    Wilmes E; Wolf H
    Laryngorhinootologie; 1989 Jan; 68(1):36-43. PubMed ID: 2536874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burkitt lymphoma: the role of Epstein-Barr virus revisited.
    Grömminger S; Mautner J; Bornkamm GW
    Br J Haematol; 2012 Mar; 156(6):719-29. PubMed ID: 22482131
    [No Abstract]   [Full Text] [Related]  

  • 32. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
    Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS
    J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
    Vockerodt M; Tesch H; Kube D
    Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus infections and their association with human malignancies: some key questions.
    Griffin BE; Xue SA
    Ann Med; 1998 Jun; 30(3):249-59. PubMed ID: 9677010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
    Klein G; Klein E; Kashuba E
    Biochem Biophys Res Commun; 2010 May; 396(1):67-73. PubMed ID: 20494113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the effect of human herpesvirus 6 on replication of Epstein-Barr virus].
    Xia Q; Meng G; Ai Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 33(4):235-6. PubMed ID: 11717892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
    Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
    J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virology. Epstein-Barr virus turns 50.
    Lieberman PM
    Science; 2014 Mar; 343(6177):1323-5. PubMed ID: 24653027
    [No Abstract]   [Full Text] [Related]  

  • 40. In situ amplification of the Epstein-Barr virus genome in cell suspensions.
    Fares F; Habib M; Verniol C; Drouet E; Niveleau A
    J Virol Methods; 1998 Apr; 71(2):211-8. PubMed ID: 9626954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.